Cargando…
Effective treatment of squamous cell carcinomas with ingenol mebutate gel in immunologically intact SKH1 mice
Ingenol mebutate has recently been approved by the Federal Drug Administration (USA) as a topical treatment for actinic keratoses. Herein, we describe the efficacy of ingenol mebutate for the topical treatment of squamous cell carcinoma (SCC) using a wild-type mouse model (SKH1) and the UV-induced m...
Autores principales: | Cozzi, Sarah-Jane, Le, Thuy T., Ogbourne, Steven M., James, Cini, Suhrbier, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3535356/ https://www.ncbi.nlm.nih.gov/pubmed/22871992 http://dx.doi.org/10.1007/s00403-012-1270-0 |
Ejemplares similares
-
Tattoo removal with ingenol mebutate
por: Cozzi, Sarah-Jane, et al.
Publicado: (2017) -
IL-1 Contributes to the Anti-Cancer Efficacy of Ingenol Mebutate
por: Le, Thuy T., et al.
Publicado: (2016) -
Ingenol mebutate treatment in keloids
por: De Felice, Bruna, et al.
Publicado: (2015) -
New developments in the treatment of actinic keratosis: focus on ingenol mebutate gel
por: Berman, Brian
Publicado: (2012) -
A Case of Bowen's Disease Successfully Treated with Ingenol Mebutate Gel
por: Chae, Je-Byeong, et al.
Publicado: (2017)